Skip to content

OnKure Therapeutics, Inc. OKUR Book value per share

Book value per share at other companies

Pfizer logo
PfizerPFE
$15.72-0.6%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
-$1.35-122%
Replimune Group logo
Replimune GroupREPL
$2.28-60.5%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$10.57-8.8%
Erasca, Inc. logo
Erasca, Inc.ERAS
$1.29-8.3%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$4.18-22.6%

Other financials

Income statement

See full
Revenue-
Operating income-$15.6M+8.1%
Net income-$15.2M+4.8%
EPS (diluted)-$1.11+6.7%

Balance sheet

See full
Cash & equivalents$192.1M+98.7%
Total debt$409.0K-57.2%
Total equity$184.4M+103%
Total assets$198.7M+98.9%

Cash flow

See full
Operating cash flow-$12.9M+7.6%
CapEx$5.0K-72.2%
Free cash flow-$12.9M+7.7%

Valuation

See full
Market cap$184.2M+72.6%
Enterprise value-$7.49M-127%

Returns & leverage

See full
Return on equity-42.7%
Debt / equity0.0×
Current ratio13.8×+2.6×

Where this comes from

Calculated from OnKure Therapeutics, Inc.’s reported figures.

Based on the most recent quarter.

The official record: OnKure Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about OnKure Therapeutics, Inc.'s book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OnKure Therapeutics, Inc.'s book value per share?
OnKure Therapeutics, Inc. (OKUR) reported book value per share of $13.48 in Q1 2026.
How has OnKure Therapeutics, Inc.'s book value per share changed year-over-year?
OnKure Therapeutics, Inc.'s book value per share increased by 99.7% year-over-year, from $6.75 to $13.48.
What is the long-term trend for OnKure Therapeutics, Inc.'s book value per share?
Over 5 years (2020 to 2025), OnKure Therapeutics, Inc.'s book value per share has grown at a -27.5% compound annual growth rate (CAGR), from -$20.76 to $4.16.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.